LOS ANGELES, March 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fulgent Genetics, Inc. (“Fulgent" or the "Company") (NASDAQ:FLGT) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or join the case via https://portnoylaw.com/fulgent-genetics-inc. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
Fulgent’s stock price plummeted $9.43 per share, or 38.09%, to close at $15.33 per share on February 27, 2026, thereby injuring investors. This massive valuation collapse followed a February 27, 2026, press release detailing the Company's fourth quarter and full year 2025 financial results. The primary driver of the decline was the Company's lower-than-expected guidance for 2026, which management admitted was a direct result of its "largest customer moving a significant volume of its work in-house." This strategic shift by a key partner fundamentally altered Fulgent's projected revenue streams and growth trajectory. The revelation that such a substantial portion of the Company's business would be internalized by its primary client led to an immediate and severe erosion of shareholder value as the market adjusted to the diminished future earnings potential.
The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising
